Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01026922 · ClinicalTrials.gov registry record
Use of an Ambulatory Capsule to Characterize Gastrointestinal Pressure Patterns in Children
A clinical trial of Upper Gastrointestinal Motility Disorders, sponsored by Nationwide Children's Hospital.
- Completed
- Registry status
- 22
- Enrollment target
- 1
- Study location
NCT01026922: Completed study of Upper Gastrointestinal Motility Disorders, sponsored by Nationwide Children's Hospital.
NCT01026922 is a study of Upper Gastrointestinal Motility Disorders that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 22 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01026922, a study of Upper Gastrointestinal Motility Disorders, has completed, sponsored by Nationwide Children's Hospital.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test a new medical device called the SmartPill GI Monitoring System, which is now used to diagnose gastric motility disorders in adults, in children. The study will compare the SmartPill capsule findings to antroduodenal manometry (ADM), which is a standard procedure currently used for the evaluation of gastric and duodenal motility in children. The ADM studies will be done for clinical purposes and only if recommended by the patient's gastroenterologist. The research portion of the study is limited to the use of SmartPill.
Primary Outcome
Determine if a patient's gastric and duodenal motility is considered normal or abnormal, if their motility disorder considered as neuropathic (normal amplitude of contractions) or myopathic (low amplitude or absent contractions) based on ADM vs SmartPill. The goal is to identify the diagnostic yield of each test and exploring how they compare in detecting motor abnormalities in the GI tract.
Conditions Studied
Study Locations (1)
Ohio
- Center for Digestive Disorders at Nationwide Childrens Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2009-12 |
| Est. Completion | 2011-06 |
What the finished NCT01026922 record still lists
NCT01026922 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.
The record links to 1 condition, with Upper Gastrointestinal Motility Disorders appearing as the primary indexed condition, and to 0 interventions.
NCT01026922 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT01026922 about?
NCT01026922 is a clinical study titled "Use of an Ambulatory Capsule to Characterize Gastrointestinal Pressure Patterns in Children". This study will test a new medical device called the SmartPill GI Monitoring System, which is now used to diagnose gastric motility disorders in adults, in children. The study will compare the SmartPill capsule findings to antroduodenal manometry (ADM), which is a standard procedure currently used f...
What is the current status of trial NCT01026922?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2009-12. Estimated completion is 2011-06.
What conditions does trial NCT01026922 study?
This clinical trial studies the following conditions: Upper Gastrointestinal Motility Disorders.
Who is sponsoring clinical trial NCT01026922?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01026922 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia